Hormonal emergency contraception

Pharmacotherapy

Volumn 22, Issue 1, 2002, Pages 43-53

  Wanner, Melissa Sanders ^a   Couchenour, Rachel L ^b  

^a TEMPLE UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; ESTROGEN; GESTAGEN; GONADOTROPIN ANTAGONIST; LEVONORGESTREL; MIFEPRISTONE;

DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFORMATION; DRUG TOLERABILITY; FEMALE; HEALTH CARE ACCESS; HORMONAL CONTRACEPTION; HUMAN; NAUSEA; PREGNANCY; REVIEW; UNITED STATES; VOMITING;

CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; CONTRACEPTIVES, POSTCOITAL, HORMONAL; DANAZOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEVONORGESTREL; MIFEPRISTONE; NAUSEA; PREGNANCY; VOMITING;

EID: 0036138788     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.1.43.33499     Document Type: Review

References (47)

1. Emergency postcoital contraception
2. Prescription drug products: Certain combined oral contraceptives for use as postcoital emergency contraception
3. Emergency contraception
4. Emergency contraceptive pills: A simple proposal to reduce unintended pregnancies
5. Interception: Post-coital estrogens in 3016 women
6. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive
7. Comparison of Yuzpe regimen, danazol, and mifepristone (RU 486) in oral postcoital contraception
8. Hormonal postcoital contraception with an ethinyl estradiol-norgestrel combination and two danazol regimens
9. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception
10. Statistical evidence about the mechanism of action of the Yuzpe regimen of emergency contraception
11. Mode of action of dl-norgestrel and ethinyl-estradiol combination in postcoital contraception. III. Effect of pre-ovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis
12. Mode of action of dl-norgestrel and ethinyl-estradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium
13. Mode of action of dl-norgestrel and ethinyl-estradiol combination in postcoital contraception
14. A possible mechanism of action of danazol and ethinyl-estradiol/norgestrel combination used as postcoital contraceptive agents
15. Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle
16. Timing of sexual intercourse in relation to ovulation: Effects on the probability of conception, survival of the pregnancy, and sex of the baby
17. The timing of the "fertile window" in the menstrual cycle: Day specific estimates from a prospective study
18. Post-coital contraception: A pilot study
19. A multi-center clinical investigation employing ethinyl estradiol combined with dl-norgestrel as a postcoital contraceptive agent
20. Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception
21. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception
22. A comparison of high-dose estrogens versus low-dose ethinyl estradiol and norgestrel combination in postcoital interception: A study of 493 women
23. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception
24. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen
25. Meclizine for prevention of nausea associated with use of emergency contraceptive pills: A randomized trial
26. Emergency oral contraception: Clinical management guidelines for obstetricians and gynecologists
27. Apparent interaction between warfarin and levonorgestrel used for emergency contraception
28. Mifepristone (RU 486): Current knowledge and future prospects
29. Mifepristone (RU 486): A review
30. Mifepristone (RU 486): A modulator of progestin and glucocorticoid action
31. RU 486: The progesterone antagonist
32. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters, and endometrium
33. Danazol: Endocrine pharmacology and therapeutic applications
34. Access to emergency contraception
35. Emergency contraception: A national survey of adolescent health experts
36. Using pharmacies in Washington State to expand access to emergency contraception
37. Improving access to emergency contraception
38. Emergency contraception from pharmacists misses opportunity
39. FDA approves mifepristone for the termination for early pregnancy
40. Interventions for emergency contraception